Compound Detail
CHEMBL184618
FRAMYCETIN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O
Basic Information
| ChEMBL ID | CHEMBL184618 |
| Name | FRAMYCETIN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | PGBHMTALBVVCIT-VCIWKGPPSA-N |
14
Targets
85
Activities
4
Assay Types
3
PK Parameters
20
Publications
14
Known Names
3
Indications
Molecular Properties
614.6
MW (Da)
-8.90
ALogP
19
HBA
13
HBD
353.1
PSA (Ų)
0.11
QED
3
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Eye Infections Nasal Obstruction Osteomyelitis
ATC Classification
D09AA01
framycetin
Level 1: DERMATOLOGICALS
Level 2: MEDICATED DRESSINGS
R01AX08
framycetin
Level 1: RESPIRATORY SYSTEM
Level 2: NASAL PREPARATIONS
S01AA07
framycetin
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
Kd 52 meas. best 9.0
IC50 28 meas. best 8.1
Ki 4 meas. best 8.15
EC50 1 meas. best 8.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Kd | 9.0 | 6.0253 | 1.0 | 19 |
| Nucleic Acid CHEMBL345 | EC50 | 8.15 | 8.15 | 7.0 | 1 |
| Lethal factor CHEMBL4372 | Ki | 8.15 | 7.225 | 7.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.1 | 5.5811 | 7.9 | 9 |
| Ribosomal RNA A-site CHEMBL614640 | Kd | 7.72 | 7.72 | 19.0 | 1 |
| Bacterial 70S ribosome CHEMBL2363135 | IC50 | 7.5 | 7.5 | 32.0 | 1 |
| Nucleic Acid CHEMBL345 | Kd | 7.22 | 6.1684 | 60.0 | 19 |
| Ribosomal RNA A-site CHEMBL614640 | IC50 | 7.12 | 7.0133 | 76.0 | 3 |
| No relevant target CHEMBL2362975 | Kd | 7.0 | 6.1933 | 100.0 | 3 |
| microRNA 21 CHEMBL1615322 | Kd | 7.0 | 6.105 | 100.0 | 4 |
| Rev responsive element (RRE) RNA CHEMBL613297 | Kd | 6.75 | 6.59 | 180.0 | 2 |
| Human immunodeficiency virus type 1 REV CHEMBL3852 | Kd | 6.75 | 6.75 | 180.0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 CHEMBL4794 | IC50 | 6.4 | 6.4 | 400.0 | 1 |
| Nucleic Acid CHEMBL345 | IC50 | 6.38 | 6.0833 | 417.0 | 3 |
| Bacillus subtilis CHEMBL359 | Kd | 5.07 | 5.07 | 8500.0 | 1 |
| Escherichia coli CHEMBL354 | IC50 | 4.98 | 4.98 | 10500.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 4.87 | 4.8 | 13500.0 | 2 |
| Lecithin retinol acyltransferase CHEMBL2202 | IC50 | 4.83 | 4.83 | 14900.0 | 1 |
| Menin CHEMBL1615381 | Kd | 4.81 | 4.81 | 15600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Ka | 2.6 | 10'7/M | - |
| Ka | 9.9 | 10'6/M | - |
| Ka | 1.6 | 10^-5M | Not specified |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine